Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Biomedica spins out Panacos, gets $3mm in funding

Executive Summary

Boston Biomedica has spun out its drug discovery and therapeutics arm, Panacos Pharmaceuticals. Investors AM Pappas & Associates and Ampersand Ventures paid $3mm in cash for 2.7mm shares of Panacos' Series B preferred stock, which represents 54.7% of the company.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies